Log In
Print this Print this

Hepatitis B vaccine (ABX203)

  Manage Alerts
Collapse Summary General Information
Company Abivax S.A.S.
DescriptionTherapeutic vaccine composed of recombinant hepatitis B surface antigen (HBsAg) and hepatitis B core antigen (HBcAg)
Molecular Target Hepatitis B surface antigen (HBsAg) ; Hepatitis B core antigen (HBcAg)
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase II/III
Standard IndicationHepatitis B virus (HBV)
Indication DetailsTreat chronic HBV infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today